Morning (vs Evening) Dosing and Better Survival in Glioblastoma ...Middle East

Medscape - News
Taking temozolomide in the morning, rather than the evening, was associated with improved survival in some patients with newly diagnosed glioblastoma. Medscape Medical News

Hence then, the article about morning vs evening dosing and better survival in glioblastoma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Morning (vs Evening) Dosing and Better Survival in Glioblastoma )

Apple Storegoogle play

Last updated :

Also on site :